Lung cancer Posts on Medivizor
Navigation Menu

Lung cancer Posts on Medivizor

Can bisphosphonates improve treatment outcomes for patients with lung cancer spread to the bones?

Posted by on Nov 3, 2019 in Lung cancer | 0 comments

In a nutshell This study evaluated whether zoledronate (Zometa) combined with TKI therapy is more effective than TKI therapy alone for patients with non-small cell lung cancer (NSCLC) spread to the bones. This study concluded that adding zoledronate to TKI therapy improved survival outcomes for these patients. Some background NSCLC is the most common...

Read More

Can adding chemotherapy agents to gefitinib improve outcomes for advanced NSCLC?

Posted by on Oct 28, 2019 in Lung cancer | 0 comments

In a nutshell This study investigated whether adding chemotherapy agents to gefitinib (Iressa) improved outcomes for patients with advanced non-small cell lung cancer (NSCLC). This study found that this combination improved survival but increased side effects for these patients. Some background The gene for epidermal growth factor receptor...

Read More

Evaluating the safety and effectiveness of pembrolizumab in elderly patients with advanced non-small cell lung cancer

Posted by on Oct 20, 2019 in Lung cancer | 0 comments

In a nutshell This study investigated the safety and effectiveness of pembrolizumab (Keytruda) in patients of 75 years or older with PD-L1 positive non-small-cell-lung cancer (NSCLC). Authors concluded that pembrolizumab improved overall survival and was safer than chemotherapy in these patients. Some background Lung cancer is one of the most common...

Read More

Should additional chemotherapy be added to chemoradiotherapy in patients with inoperable non-small cell lung cancer?

Posted by on Oct 20, 2019 in Lung cancer | 0 comments

In a nutshell This study examined how effective additional chemotherapy alongside chemo-radiotherapy is in patients with locally advanced non-small cell lung cancer. The study found that additional chemotherapy did not bring survival benefits in these patients. Some background Non-small cell lung cancer (NSCLC) can be difficult to treat. There are a...

Read More

Atezolizumab in non-squamous non-small cell lung cancer – is it effective when combined with chemotherapy?

Posted by on Oct 12, 2019 in Lung cancer | 0 comments

In a nutshell This study investigated if atezolizumab (Tecentriq) combined with chemotherapy (CT) is effective in patients with advanced non-squamous non-small cell lung cancer (NS-NSCLC). They found that this treatment improved survival in these patients. Some background Non-small cell lung cancer (NSCLC) is the most common lung cancer...

Read More

Epidermal growth factor ointment improves the treatment of skin side effects in patients receiving treatment for lung cancer

Posted by on Sep 26, 2019 in Lung cancer | 0 comments

In a nutshell This study investigated the effectiveness of epidermal growth factor (EGF) ointment to treat skin side effects in patients with non-small cell lung cancer (NSCLC) receiving epidermal growth factor receptor (EGFR) inhibitor treatment. Researchers suggested that EGF ointment improves the outcomes and quality of life of these patients. Some...

Read More

Nivolumab in previously treated advanced non-small cell lung cancer – what is the long-term outlook for survival?

Posted by on Sep 16, 2019 in Lung cancer | 0 comments

In a nutshell This study investigated survival rates in advanced non-small cell lung cancer (NSCLC) after nivolumab (Opdivo) treatment.  They found that nivolumab was associated with longer survival time in patients that responded to treatment.  Some background Lung cancer (LC) is one of the most common cancers worldwide. Non-small...

Read More